Nitrostat Sublingual Tablets 0.4mg 1/150gr Bottle 4x25/Package , Pfizer 00071041813
$215.00
$181.99
Nitrostat Sublingual Tablets 0.4mg 1/150gr Bottle 4x25/Package , Pfizer 00071041813
1- REGULATIONS ON PURCHASE OF THESE PRODUCTS VARY FROM STATE TO STATE . IT IS THE PURCHASER'S RESPONSIBILITY TO KNOW AND COMPLY WITH THE LAWS GOVERNING THE DISTRICT IN WHICH THEY LIVE. <BR> 2-THESE ITEMS WOULD BE USED ONLY BY QUALIFIED CUSTOMERS ( PHYSICIAN OFFICES , DIAGNOSTIC & RESEARCH LABORATORIES , HEALTH CARE PROVIDERS , .... ) WITH VALID PROFESSIONAL LICENSE. <BR> 3- ANY INQUIRY REGARDING THESE ITEMS WOULD BE PROCESSED AFTER VERIFICATION OF VALID LICENSE TO BE EMAILED AS AN ATTACHMENT TO : ADMIN@ALLMEDTECH.COM OR FAXED TO 323-782-0985 )
| Manufacturer # | 00071041813 |
| Brand | Nitrostat® |
| Manufacturer | Pfizer |
| Application | Nitrate |
| Container Type | Bottle |
| Dosage Form | Tablet |
| Generic Drug Code | 01772 |
| Generic Drug Name | Nitroglycerin |
| NDC Number | 00071-0418-13 |
| Storage Requirements | USP Controlled Room Temperature |
| Strength | 0.4 mg |
| Type | Sublingual |
| UNSPSC Code | 51411605 |
| Volume | 25 Tablets |
Features
- NITROSTAT is a stabilized sublingual compressed nitroglycerin tablet
- The principal pharmacological action of nitroglycerin is relaxation of vascular smooth muscle
- Although venous effects predominate, nitroglycerin produces, in a dose-related manner, dilation of both arterial and venous beds
- Therapeutic doses of nitroglycerin may reduce systolic, diastolic, and mean arterial blood pressure
- Nitroglycerin is indicated for the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease
- NITROSTAT is a sublingual tablet and should not be chewed, crushed, or swallowed
Featured Products
